Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 280 results for "cipla"

Stock Talk: Ruchit Jain on Dr Reddy's, Cipla, ITC
NDTV Profit

Stock Talk: Ruchit Jain on Dr Reddy's, Cipla, ITC

Ruchit Jain of Angel Broking Ruchit Jain of Angel Broking believes that there is still upside in the markets. The market has potential to go up to 8500 in the next couple of days, he says. The markets will be rangebound where 8300 is the support ... NDTV Profit, 1 day ago
India Infoline

Cipla ends 5% up; partner gets USFDA approval

NEW DELHI: Shares of Cipla surged over 4 per cent in trade on Thursday after its partner Sandoz received a USFDA nod to launch a generic version of Pulmicort respules. ET Now reported that Cipla will supply active pharmaceutical ingredients (APIs) ...
 Economic Times2 days ago Cipla surges after its partner Sandoz received USFDA nod for a key drug  Business Standard India2 days ago Cipla gains as partner Sandoz gets USFDA approval for generic drug  Economic Times2 days ago Cipla gains 5% as partner Sandoz gets USFDA nod for generic drug  India Infoline2 days ago

Cipla perks up over 3% on BSE

Cipla was the top gainer on the BSE on Thursday morning. At 11.04 am the share was trading at Rs 703, up 3.74 per cent on its overnight close at Rs 677.65. HDFC gained 2.61 per cent
 Hindu Business Line2 days ago Hindustan Unilever up nearly 3% on NSE  Hindu Business Line2 days ago BoB vaults over 10% on NSE  Hindu Business Line2 days ago Dr Reddy's surges nearly 6% on BSE  Hindu Business Line2 days ago
VC Circle

Cipla climbs 2%; Fidelity to invest in consumer healthcare business

We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits. Free Portfolio of Equity and Assets Exclusive E-newsletter Post Comments and Share Feedback Your Personal Page Access Premium Services ...
 India Infoline1 week ago Consumer health mkt growing at high double digit: Cipla  Money Control1 week ago Fidelity To Invest In Cipla's Healthcare Arm  Deal Curry1 week ago Cipla to divest stake in consumer healthcare business to Fidelity Growth Partners  VC Circle1 week ago
Bio Spectrum Asia

Cipla remembers AIDS pioneer

Drugmaker Cipla has paid tributes to AIDS pioneer Dr Suniti Solomon, recalling their work together during the early days when the illness was diagnosed in the country. Dr Solomon passed away earlier this week in Chennai. Dr Solomon, professor of ...
 Hindu Business Line2 days ago Cipla: Affordable drugmaker  Bio Spectrum Asia3 weeks ago Lupin, Cipla bidding for UCB SA's US generic drugs business: Reports  India Infoline2 months ago Lupin, Cipla eye UCB’s $1b generic drug unit  The Financial Chronicle2 months ago
India Infoline

Cipla rises 4% on asthma drug launch, Kotak says buy

Kotak has a buy rating on Cipla with a target price of Rs 730 per share. Expecting launch of other two strengths (USD 600 million) in days to follow , the brokerage says Cipla will receive mark-up and profit share.
 Money Control2 days ago Cipla drops as Mylan launches asthma drug  India Infoline1 month ago Cipla declines on negative outlook from a foreign brokerage  Business Standard1 month ago Mylan's Asthma drug launch in UK negative for Cipla: BoAML  Money Control1 month ago

In consolidation mode: Sensex jumps over 200 points; Cipla, HDFC top gains

Market breadth was firm with 1,552 stocks advancing against 537 declines on BSE The post In consolidation mode: Sensex jumps over 200 points; Cipla, HDFC top gains appeared first on Firstpost .
 First Post.com2 days ago

Cipla grabs 51 percent stake in Uganda firm for $26 mn

Singapore : According to reports, Indian drug giant Cipla has renegotiated payment terms for acquiring majority stake in Uganda's Quality Chemicals. The company announced that it will obtain 51 percent stake for $26 million (around Rs 166 crore) ...
 Bio Spectrum Asia3 days ago

Cipla gains after attracting investment into newly launched Consumer Healthcare business

Cipla rose 2.02% to Rs 677.30 a 10:45 IST on BSE on renewed buying interest after the company announced an investment led by Fidelity Growth Partners India into the newly launched Consumer Healthcare business. The announcement was made before ...
 Capital Market1 week ago

Cipla board approves investment in consumer healthcare division

Email this Print Indian pharmaceutical major Cipla Limited today announced that the company's board has approved a potential investment by Fidelity Growth Partners India and US-based Fidelity Biosciences, through FIL Capital ...
 Smart Investor1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cipla
Get updated on latest news & your favorite topics right in your inbox!
More     Less